Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889260 · ClinicalTrials.gov registry record
Speech Accessibility Project
A clinical trial of Parkinson Disease and Multiple System Atrophy, sponsored by University of Illinois at Urbana-Champaign.
- Completed
- Registry status
- 485
- Enrollment target
- 2
- Study locations
NCT05889260 is a study of Parkinson Disease and Multiple System Atrophy that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 485 participants, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05889260, a study of Parkinson Disease and Multiple System Atrophy, has completed, sponsored by University of Illinois at Urbana-Champaign.
- COMPLETED
- Registry status
- 485 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with atypical speech, and share this data set with researchers at other organizations. This two-year project plans to collect 1,200,000 speech samples from 2,000 people, each of whom will provide 600 samples. In Year 1, the initial focus will be people with Parkinson's. In Year 2, four more etiologies of interest will be recruited: Amyotrophic Lateral Sclerosis (ALS), Cerebral Palsy (CP), Down Syndrome (DS), and Stroke. UIUC will build an open-source software infrastructure to collect annotated speech samples and share these data in an appropriately secure fashion with researchers from our partner technology companies (and eventually, other organizations as well) so that they can use these data to improve their automatic speech recognition algorithms. This project promotes diversity, equity, and inclusion by helping technology companies to fully support all types of speech, and it is also more efficient and less burdensome for these specialized patient populations to have one centralized "collector" of speech samples.
Conditions Studied
Study Locations (2)
Colorado
- LSVT Global - Denver
Illinois
- University of Illinois at Urbana-Champaign - Urbana
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 485 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05889260
The ClinicalTrials.gov registry entry for NCT05889260 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 485 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,325-participant average among 297 other Parkinson Disease trials with a reported enrollment target (91% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05889260 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT05889260 about?
NCT05889260 is a clinical study titled "Speech Accessibility Project". The goal of the Speech Accessibility Project at the University of Illinois Beckman Institute (https://speechaccessibilityproject.beckman.illinois.edu) is to collect, annotate, and curate a shared database of speech samples from people with atypical speech, and share this data set with researchers at...
What is the current status of trial NCT05889260?
This trial is currently completed. The enrollment target is 485 participants. The study started on 2023-03-15. Estimated completion is 2025-07-31.
What conditions does trial NCT05889260 study?
This clinical trial studies the following conditions: Parkinson Disease, Multiple System Atrophy, Dementia With Lewy Bodies, Progressive Supranuclear Palsy.
Who is sponsoring clinical trial NCT05889260?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05889260 being conducted?
This trial has 2 study locations across Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.